RU2219927C1 - Ancardin-retard as agent with prolonged anti-calcium effect - Google Patents
Ancardin-retard as agent with prolonged anti-calcium effect Download PDFInfo
- Publication number
- RU2219927C1 RU2219927C1 RU2002131189A RU2002131189A RU2219927C1 RU 2219927 C1 RU2219927 C1 RU 2219927C1 RU 2002131189 A RU2002131189 A RU 2002131189A RU 2002131189 A RU2002131189 A RU 2002131189A RU 2219927 C1 RU2219927 C1 RU 2219927C1
- Authority
- RU
- Russia
- Prior art keywords
- agent
- ancardin
- retard
- effect
- diumancal
- Prior art date
Links
Images
Abstract
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to an anti-calcium agent with prolonged effect. Agent comprises as an active component the compound 7,7'-ethylenedioxybenzopyrane-2,2'-dione (diumancal) in the dose 0.02 g as a solid-dispersed system with polyethylene glycol with molecular mass 1 500 Da and this agent has the name "Ancardin-retard". Invention provides the maintenance of diumancal activity for 26 h as compared with 2 h period for the early known agent. EFFECT: enhanced effectiveness of agent. 5 tbl, 5 ex
Description
Текст описания в факсимильном виде (см. графическую часть). Description text in facsimile form (see graphic part).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002131189A RU2219927C1 (en) | 2002-11-21 | 2002-11-21 | Ancardin-retard as agent with prolonged anti-calcium effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2002131189A RU2219927C1 (en) | 2002-11-21 | 2002-11-21 | Ancardin-retard as agent with prolonged anti-calcium effect |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2219927C1 true RU2219927C1 (en) | 2003-12-27 |
RU2002131189A RU2002131189A (en) | 2004-06-10 |
Family
ID=32067159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002131189A RU2219927C1 (en) | 2002-11-21 | 2002-11-21 | Ancardin-retard as agent with prolonged anti-calcium effect |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2219927C1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2671983C1 (en) * | 2018-05-07 | 2018-11-08 | Общество С Ограниченной Ответственностью "Сир" | Anticoagulant agent of indirect action on basis of diumancal |
RU2678969C1 (en) * | 2018-03-28 | 2019-02-05 | Общество С Ограниченной Ответственностью "Сир" | Antiarrhythmic drug based on hybrid molecules of amlodipine with (7-methoxicumarin-4-yl)acetic acid |
-
2002
- 2002-11-21 RU RU2002131189A patent/RU2219927C1/en active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2678969C1 (en) * | 2018-03-28 | 2019-02-05 | Общество С Ограниченной Ответственностью "Сир" | Antiarrhythmic drug based on hybrid molecules of amlodipine with (7-methoxicumarin-4-yl)acetic acid |
RU2671983C1 (en) * | 2018-05-07 | 2018-11-08 | Общество С Ограниченной Ответственностью "Сир" | Anticoagulant agent of indirect action on basis of diumancal |
RU2671983C9 (en) * | 2018-05-07 | 2019-01-24 | Общество С Ограниченной Ответственностью "Сир" | Anticoagulant agent of indirect action on basis of diumancal |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1183014T3 (en) | Flavored controlled release oral pharmaceutical compositions | |
DE60019693D1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE ABSORPTION-CONNECTING COMPOUNDS | |
DE69926386D1 (en) | PROPOFOL FORMULATION | |
SE0003449D0 (en) | Anticancer compositions | |
BR9611802A (en) | Pharmaceutical compositions | |
HK1080364A1 (en) | Oral pharmaceutical forms of liquid drugs having improved bioavailability | |
DE69727922D1 (en) | QUICKLY DECOMPOSING ORAL DOSAGE FORM | |
BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
PT1207756E (en) | USE OF ESPINOSADE OR A FORMULATION THAT INCLUDES ESPINOSADE | |
DE69940557D1 (en) | A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER | |
DK1007006T3 (en) | Formulation of the cefadroxil monohydrate tablet | |
SE9704401D0 (en) | Matrix pellets for greasy, oily or sticky drug substances | |
FR2878158B1 (en) | ORAL PHARMACEUTICAL FORM, SOLID MICROPARTICULAR DESIGNED TO PREVENT MEASUREMENT | |
FR2771292B1 (en) | TIAGABINE-CONTAINING SPHEROIDS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
ATE290854T1 (en) | CARBAMAZEPINE SUPPORTED-RELEASE FORMULATION | |
RU2219927C1 (en) | Ancardin-retard as agent with prolonged anti-calcium effect | |
KR970706802A (en) | LOW-PRESSURE TABLETED EFFER VESCENT PREPARATION | |
FR2793685B1 (en) | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THEIR PREPARATION | |
DE60319983D1 (en) | Universal composition for controlled release of active ingredient containing chitosan | |
CA2185883A1 (en) | The use of dimeticone as a transport and carrier system and/or drug delivery system | |
EA200601015A1 (en) | ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION | |
EA200701525A1 (en) | PHARMACEUTICAL POLYMERIC COMPOSITION FOR ORAL ADMINISTRATION OF TERBUTALINE SULFATE WITH CONTROLLED DELIVERY | |
RU2002131189A (en) | ANCARDIN-RETARD-MEDICINE OF LONG-TERM ANTI-Calcium ACTION | |
DK1275383T3 (en) | "Modified release" pharmaceutical composition containing Bupropion HCl as active substance | |
FR2751967B1 (en) | ANTI-MALARIA AND ANTIBABESIOSIS AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |